James A. Mbah

Dr. James A. Mbah


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Smith BabiakaSmith Babiaka
Smith Babiaka
Conrad Simoben VeransoConrad Simoben Veranso
Conrad Simoben Veranso
KAKennedy Abuga
Kennedy Abuga
JMJames A. Mbah
James A. Mbah
RKRajshekhar Karpoormath
Rajshekhar Karpoormath
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
A new iboga-vobasine-type isomeric bisindole alkaloid named voacamine A (1), along with eight known compounds—voacangine (2), voacristine (3), coronaridine (4), tabernanthine (5), iboxygaine (6), voacamine (7), voacorine (8) and conoduramine (9)—were isolated from the stem bark of Voacangaafricana. The structures of the compounds were determined by comprehensive spectroscopic analyses. Compounds 1, 2, 3, 4, 6, 7 and 8 were found to inhibit the motility of both the microfilariae (Mf) and adult male worms of Onchocerca ochengi, in a dose-dependent manner, but were only moderately active on the adult female worms upon biochemical assessment at 30 μM drug concentrations. The IC50 values of the isolates are 2.49–5.49 µM for microfilariae and 3.45–17.87 µM for adult males. Homology modeling was used to generate a 3D model of the O. ochengi thioredoxin reductase target and docking simulation, followed by molecular dynamics and binding free energy calculations attempted to offer an explanation of the anti-onchocercal structure–activity relationship (SAR) of the isolated compounds. These alkaloids are new potential leads for the development of antifilarial drugs. The results of this study validate the traditional use of V. africana in the treatment of human onchocerciasis.

5 January 2021 in Chemical Papers
Verified
Journal Article
Closed access
PDF file
NMNapoleon A. Mfonku
Napoleon A. Mfonku
ATAlain T. Tadjong
Alain T. Tadjong
GKGabriel T. Kamsu
Gabriel T. Kamsu
NKNorbert Kodjio
Norbert Kodjio
JRJie Ren
Jie Ren
Jixun ZhanJixun Zhan
Jixun Zhan

24 June 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
SBSmith B. Babiaka
Smith B. Babiaka
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
BNBakoh Ndingkokhar
Bakoh Ndingkokhar
JMJames A. Mbah
James A. Mbah
Wolfgang SipplWolfgang Sippl
Wolfgang Sippl
JYJoseph N. Yong
Joseph N. Yong
This review is intended to highlight the relevance of natural products in drug discovery paying particular attention to those derived from Southern African medicinal plants with diverse biological activities. In this review series, a literature survey led to the collection of 864 secondary metabolites from 101 plant species from 57 plant families. A correlation between the known biological activities of isolated compounds and the ethnobotanical uses of the plants has been attempted. Part I focused on alkaloids and terpenoids, while this part is focused on the bioactivities of flavonoids, quinines and other minor, unique compound classes which correlate with their ethnobotanical uses in African traditional medicine (ATM).

14 April 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
SBSmith B. Babiaka
Smith B. Babiaka
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
LLLydia L. Lifongo
Lydia L. Lifongo
BNBakoh Ndingkokhar
Bakoh Ndingkokhar
JMJames A. Mbah
James A. Mbah
JYJoseph N. Yong
Joseph N. Yong
As a whole, the African continent is highly endowed with a huge floral biodiversity. Natural products which have been isolated from plants growing in this region have shown interesting chemical structures with diverse biological activities, which could serve as a starting point for drug discovery. In this study, a literature survey led to the collection of 864 secondary metabolites from 101 plant species from 57 plant families. A correlation between the known biological activities of isolated compounds and the ethnobotanical uses of the plants has been attempted. This review is a survey of the bioactivities of alkaloids and terpenoids which have been isolated from Southern African flora versus the ethnobotanical uses of the plants used in Southern African traditional medicine.

17 November 2020 in Preprints.org
Verified
Preprint
Open access
PDF file
Smith BabiakaSmith Babiaka
Smith Babiaka
Conrad Simoben VeransoConrad Simoben Veranso
Conrad Simoben Veranso
KAKennedy Abuga
Kennedy Abuga
JMJames A. Mbah
James A. Mbah
RKRajshekhar Karpoormath
Rajshekhar Karpoormath
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
A new iboga-vobasine-type isomeric bisindole alkaloid named voacamine A (1), along with eight known compounds, voacangine (2), voacristine (3), coronaridine (4), tabernanthine (5), iboxygaine (6), voacamine (7), voacorine (8), and conoduramine (9), were isolated from the stem bark of Voacanga africana. The structures of the compounds were determined by comprehensive spectroscopic analyses (1D- and 2D-NMR). Compounds 1, 2, 3, 4, 6, 7 and 8 were found to inhibit the motility of both the microfilariae (Mf) and adult male worms of Onchocerca ochengi, in a dose-dependent manner, but were only moderately active on the adult female worms upon biochemical assessment at 30 μM drug concentrations. The IC50 values of the isolates are 2.49-5.49 µM for microfilariae and 3.45-17.87 µM for adult males. Homology modeling was used to generate a 3D model of the the O. ochengi thioredoxin reductase target and docking simulation attempted to offer an explanation of the anti-onchocercal structure-activity relationship (SAR) of the isolated compounds. These alkaloids are new potential leads for the development of antifilirial drugs. The results of this study validate the traditional use of V. africana in the treatment of human onchocerciasis.